MedPath

Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression

Completed
Conditions
Chronic Renal Failure
Registration Number
NCT00608998
Lead Sponsor
University Hospital, Montpellier
Brief Summary

The aim of this study is to appreciate the influence of renal failure progression on vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular risk factors.

Detailed Description

The aim of this study is to appreciate the relationship between:

* extension of coronary calcifications and chronic renal failure progression

* extension of coronary calcifications and levels of osteoprotegerin (bone disease marker)

* cardiovascular risk factors and coronary calcifications

* cardiovascular risk factors and existence of cardiovascular diseases

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Patient who has signed the written consent form

  • Patient aged > 18 and < 90 years

  • Chronic renal failure defined by glomerular filtration rate (GFR)

    • group 1: GFR >90 mL/min with urinary biological abnormalities and GFR comprised between 90 and 60 mL/min
    • group 2: GFR comprised between 60 and 30 mL/min
    • group 3: GFR <30 mL/min but without dialysis therapy
Exclusion Criteria
  • Chronic renal failure patient requiring dialysis therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
description of osteoprotegerin levels according to chronic renal failure progressioninclusion
Secondary Outcome Measures
NameTimeMethod
relationship between cardiovascular risk factors and cardiovascular diseaseinclusion
osteoprotegerin description according to calcium scoreinclusion
relationship between cardiovascular risk factors and calcium scoreinclusion
calcium score description according to chronic renal failure progressioninclusion

Trial Locations

Locations (1)

Centre Hospitalier Universitaire

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath